Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sheep | 27 | 2019 | 194 | 2.800 |
Why?
|
| Mesenchymal Stem Cells | 16 | 2018 | 148 | 2.480 |
Why?
|
| Retroviridae | 9 | 2012 | 26 | 1.880 |
Why?
|
| Transduction, Genetic | 7 | 2013 | 43 | 1.660 |
Why?
|
| Cosmic Radiation | 2 | 2018 | 11 | 1.490 |
Why?
|
| Hematopoietic Stem Cells | 10 | 2018 | 93 | 1.430 |
Why?
|
| Bone Marrow Cells | 6 | 2018 | 113 | 1.290 |
Why?
|
| Cell Differentiation | 16 | 2018 | 423 | 1.280 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 10 | 2013 | 72 | 1.260 |
Why?
|
| Genetic Vectors | 11 | 2019 | 116 | 1.200 |
Why?
|
| Models, Animal | 9 | 2014 | 167 | 1.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 8 | 2016 | 94 | 1.160 |
Why?
|
| Fetus | 9 | 2016 | 73 | 1.050 |
Why?
|
| Hemophilia A | 3 | 2013 | 6 | 1.040 |
Why?
|
| Regenerative Medicine | 2 | 2015 | 185 | 0.920 |
Why?
|
| Hematopoiesis | 4 | 2018 | 33 | 0.920 |
Why?
|
| Gestational Age | 6 | 2014 | 92 | 0.910 |
Why?
|
| Antigens, CD34 | 10 | 2015 | 50 | 0.820 |
Why?
|
| Dendritic Cells | 2 | 2018 | 61 | 0.800 |
Why?
|
| Fetal Therapies | 1 | 2019 | 1 | 0.790 |
Why?
|
| Animals | 32 | 2019 | 7519 | 0.760 |
Why?
|
| Weightlessness | 1 | 2018 | 4 | 0.750 |
Why?
|
| Factor VIII | 3 | 2013 | 14 | 0.720 |
Why?
|
| Transgenes | 3 | 2008 | 46 | 0.720 |
Why?
|
| Gene Transfer Techniques | 3 | 2019 | 65 | 0.720 |
Why?
|
| Immunity, Innate | 1 | 2018 | 64 | 0.720 |
Why?
|
| Stem Cells | 6 | 2018 | 288 | 0.650 |
Why?
|
| Hematologic Diseases | 2 | 2015 | 24 | 0.630 |
Why?
|
| Immune Tolerance | 3 | 2015 | 64 | 0.610 |
Why?
|
| Stem Cell Transplantation | 5 | 2010 | 209 | 0.570 |
Why?
|
| Immunomodulation | 2 | 2013 | 27 | 0.560 |
Why?
|
| Receptors, Virus | 2 | 2012 | 15 | 0.560 |
Why?
|
| Immunity, Humoral | 1 | 2013 | 12 | 0.540 |
Why?
|
| Dependovirus | 1 | 2013 | 21 | 0.540 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 22 | 0.520 |
Why?
|
| Antibodies, Viral | 1 | 2013 | 50 | 0.520 |
Why?
|
| Pregnancy | 10 | 2019 | 749 | 0.520 |
Why?
|
| Liver Regeneration | 2 | 2010 | 24 | 0.510 |
Why?
|
| Fetal Blood | 4 | 2018 | 29 | 0.490 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2019 | 8 | 0.470 |
Why?
|
| Humans | 36 | 2019 | 29158 | 0.470 |
Why?
|
| Uterus | 2 | 2019 | 76 | 0.470 |
Why?
|
| Graft Survival | 6 | 2016 | 234 | 0.450 |
Why?
|
| Liver Diseases | 1 | 2010 | 62 | 0.410 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 89 | 0.400 |
Why?
|
| Germ Cells | 1 | 2009 | 11 | 0.390 |
Why?
|
| Antigen Presentation | 1 | 2008 | 8 | 0.370 |
Why?
|
| DNA Damage | 2 | 2018 | 92 | 0.350 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 1033 | 0.340 |
Why?
|
| Cell Proliferation | 6 | 2018 | 605 | 0.330 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 206 | 0.330 |
Why?
|
| Mice | 6 | 2019 | 2367 | 0.320 |
Why?
|
| Transplantation, Heterologous | 10 | 2015 | 126 | 0.320 |
Why?
|
| Proviruses | 1 | 2005 | 3 | 0.310 |
Why?
|
| Cell Movement | 3 | 2012 | 174 | 0.310 |
Why?
|
| Spermatozoa | 1 | 2005 | 25 | 0.300 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 65 | 0.290 |
Why?
|
| Endothelial Cells | 3 | 2016 | 172 | 0.290 |
Why?
|
| Fetal Diseases | 1 | 2004 | 13 | 0.270 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 160 | 0.270 |
Why?
|
| Gene Expression Profiling | 2 | 2005 | 346 | 0.270 |
Why?
|
| Neoplasms | 1 | 2010 | 683 | 0.250 |
Why?
|
| Intestines | 2 | 2013 | 48 | 0.250 |
Why?
|
| Cytomegalovirus | 2 | 2013 | 13 | 0.250 |
Why?
|
| Female | 13 | 2019 | 18849 | 0.250 |
Why?
|
| Viral Proteins | 2 | 2013 | 40 | 0.250 |
Why?
|
| Bone Marrow Transplantation | 2 | 2016 | 79 | 0.240 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 256 | 0.230 |
Why?
|
| Flow Cytometry | 4 | 2010 | 173 | 0.200 |
Why?
|
| Islets of Langerhans | 2 | 2010 | 73 | 0.200 |
Why?
|
| Cell Lineage | 5 | 2013 | 66 | 0.200 |
Why?
|
| Consensus | 1 | 2019 | 61 | 0.190 |
Why?
|
| Prenatal Care | 1 | 2019 | 33 | 0.190 |
Why?
|
| Liver | 4 | 2012 | 473 | 0.190 |
Why?
|
| Bleomycin | 1 | 2018 | 12 | 0.190 |
Why?
|
| Astronauts | 1 | 2018 | 6 | 0.190 |
Why?
|
| Solar Energy | 1 | 2018 | 3 | 0.190 |
Why?
|
| Bystander Effect | 1 | 2018 | 5 | 0.190 |
Why?
|
| Protons | 1 | 2018 | 22 | 0.190 |
Why?
|
| DNA Repair | 1 | 2018 | 50 | 0.180 |
Why?
|
| Histones | 1 | 2018 | 47 | 0.180 |
Why?
|
| Hepatocytes | 4 | 2007 | 77 | 0.180 |
Why?
|
| Iron | 1 | 2018 | 109 | 0.170 |
Why?
|
| Organ Specificity | 3 | 2006 | 85 | 0.170 |
Why?
|
| Stem Cell Niche | 2 | 2014 | 24 | 0.170 |
Why?
|
| Sheep, Domestic | 2 | 2016 | 18 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 253 | 0.160 |
Why?
|
| Blood Transfusion, Intrauterine | 1 | 2016 | 4 | 0.160 |
Why?
|
| Cells, Cultured | 5 | 2018 | 789 | 0.160 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 56 | 0.160 |
Why?
|
| Transplantation Chimera | 5 | 2007 | 22 | 0.160 |
Why?
|
| Models, Biological | 2 | 2008 | 372 | 0.150 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 50 | 0.150 |
Why?
|
| Electromagnetic Fields | 1 | 2015 | 36 | 0.150 |
Why?
|
| Tissue Distribution | 2 | 2013 | 52 | 0.150 |
Why?
|
| Injections, Intraperitoneal | 2 | 2011 | 40 | 0.140 |
Why?
|
| Amniotic Fluid | 1 | 2015 | 85 | 0.140 |
Why?
|
| Neutralization Tests | 1 | 2013 | 12 | 0.140 |
Why?
|
| Capsid | 1 | 2013 | 9 | 0.140 |
Why?
|
| Immune Evasion | 1 | 2013 | 2 | 0.140 |
Why?
|
| Epitopes | 1 | 2013 | 19 | 0.140 |
Why?
|
| Phenotype | 3 | 2011 | 665 | 0.130 |
Why?
|
| Luciferases | 1 | 2013 | 25 | 0.130 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 72 | 0.130 |
Why?
|
| Transplantation, Homologous | 2 | 2016 | 122 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2013 | 267 | 0.130 |
Why?
|
| Transplantation, Autologous | 2 | 2015 | 86 | 0.130 |
Why?
|
| Complement System Proteins | 1 | 2013 | 9 | 0.130 |
Why?
|
| Immediate-Early Proteins | 1 | 2013 | 13 | 0.130 |
Why?
|
| Receptor, EphB2 | 1 | 2013 | 7 | 0.130 |
Why?
|
| Viral Envelope Proteins | 1 | 2013 | 15 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2013 | 34 | 0.130 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 59 | 0.120 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 163 | 0.120 |
Why?
|
| Genetic Engineering | 1 | 2012 | 19 | 0.120 |
Why?
|
| Cell Line | 3 | 2012 | 433 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 34 | 0.120 |
Why?
|
| Killer Cells, Natural | 2 | 2012 | 21 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 85 | 0.120 |
Why?
|
| Hemarthrosis | 1 | 2011 | 3 | 0.120 |
Why?
|
| Sus scrofa | 1 | 2011 | 44 | 0.120 |
Why?
|
| Remission Induction | 1 | 2011 | 88 | 0.120 |
Why?
|
| Isoantibodies | 1 | 2011 | 11 | 0.120 |
Why?
|
| Antibody Specificity | 2 | 2008 | 15 | 0.110 |
Why?
|
| Blotting, Western | 1 | 2012 | 280 | 0.110 |
Why?
|
| Adult | 2 | 2019 | 8705 | 0.110 |
Why?
|
| Hemorrhage | 1 | 2011 | 105 | 0.110 |
Why?
|
| Insulin | 2 | 2010 | 367 | 0.110 |
Why?
|
| Immunosuppression | 1 | 2010 | 82 | 0.100 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 29 | 0.100 |
Why?
|
| Sertoli Cells | 1 | 2009 | 5 | 0.100 |
Why?
|
| Docosahexaenoic Acids | 1 | 2009 | 19 | 0.100 |
Why?
|
| Autoantigens | 1 | 2008 | 15 | 0.090 |
Why?
|
| Thymus Gland | 1 | 2008 | 17 | 0.090 |
Why?
|
| DNA | 2 | 2010 | 205 | 0.090 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 13 | 0.090 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2008 | 8 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2008 | 34 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2007 | 6 | 0.090 |
Why?
|
| Stromal Cells | 1 | 2008 | 73 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2008 | 139 | 0.080 |
Why?
|
| Time Factors | 4 | 2009 | 2091 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2009 | 180 | 0.080 |
Why?
|
| Apoptosis | 1 | 2009 | 371 | 0.080 |
Why?
|
| Male | 3 | 2011 | 18549 | 0.080 |
Why?
|
| RNA, Messenger | 4 | 2013 | 544 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2004 | 82 | 0.080 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2005 | 1 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 175 | 0.070 |
Why?
|
| Age Factors | 1 | 2009 | 1182 | 0.070 |
Why?
|
| Transfection | 1 | 2005 | 185 | 0.070 |
Why?
|
| Testis | 1 | 2005 | 63 | 0.070 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 34 | 0.070 |
Why?
|
| Infusions, Parenteral | 1 | 2005 | 70 | 0.070 |
Why?
|
| Bone Marrow | 3 | 2014 | 60 | 0.070 |
Why?
|
| Tissue Engineering | 1 | 2010 | 604 | 0.070 |
Why?
|
| Purkinje Fibers | 1 | 2004 | 3 | 0.070 |
Why?
|
| Fetal Heart | 1 | 2004 | 5 | 0.070 |
Why?
|
| Mesoderm | 1 | 2002 | 14 | 0.060 |
Why?
|
| Lung | 1 | 2005 | 237 | 0.060 |
Why?
|
| Gene Expression | 2 | 2016 | 342 | 0.060 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2002 | 4 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2002 | 5 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 15 | 0.060 |
Why?
|
| Risk Factors | 1 | 2009 | 3708 | 0.050 |
Why?
|
| Immunophenotyping | 2 | 2009 | 46 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 498 | 0.050 |
Why?
|
| Ferrets | 1 | 2018 | 18 | 0.050 |
Why?
|
| Kidney | 1 | 2002 | 477 | 0.050 |
Why?
|
| Cell Separation | 2 | 2009 | 90 | 0.050 |
Why?
|
| Brain | 1 | 2005 | 969 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 2009 | 98 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 23 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2016 | 25 | 0.040 |
Why?
|
| Antigens, CD | 2 | 2008 | 102 | 0.040 |
Why?
|
| Chondrogenesis | 1 | 2015 | 17 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 30 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2015 | 74 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2015 | 70 | 0.040 |
Why?
|
| Fetal Development | 1 | 2014 | 26 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2014 | 45 | 0.030 |
Why?
|
| Secretory Vesicles | 1 | 2013 | 2 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 66 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2012 | 17 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2013 | 36 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2012 | 19 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2012 | 11 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 67 | 0.030 |
Why?
|
| Thrombin | 1 | 2012 | 19 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2012 | 36 | 0.030 |
Why?
|
| Cricetinae | 1 | 2012 | 62 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 85 | 0.030 |
Why?
|
| Kanamycin Kinase | 1 | 2012 | 2 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2012 | 22 | 0.030 |
Why?
|
| Protein Binding | 1 | 2012 | 198 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 115 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2012 | 32 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2012 | 144 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 135 | 0.030 |
Why?
|
| Reference Standards | 1 | 2010 | 28 | 0.030 |
Why?
|
| DNA Primers | 1 | 2010 | 91 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 706 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2009 | 7 | 0.030 |
Why?
|
| Base Sequence | 1 | 2010 | 237 | 0.030 |
Why?
|
| Mitosis | 1 | 2009 | 22 | 0.030 |
Why?
|
| Annexin A5 | 1 | 2009 | 7 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 11 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2009 | 16 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 45 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 34 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 189 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2008 | 3 | 0.020 |
Why?
|
| Cell-Derived Microparticles | 1 | 2008 | 5 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 184 | 0.020 |
Why?
|
| Antigens, CD7 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2008 | 4 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2008 | 6 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 14 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2008 | 19 | 0.020 |
Why?
|
| Clone Cells | 1 | 2007 | 40 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 3153 | 0.020 |
Why?
|
| Cell Survival | 1 | 2009 | 285 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2008 | 75 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2007 | 26 | 0.020 |
Why?
|
| Injections | 1 | 2007 | 66 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 670 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2010 | 498 | 0.020 |
Why?
|
| Mitochondria | 1 | 2008 | 181 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 728 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2008 | 539 | 0.020 |
Why?
|
| Lac Operon | 1 | 2005 | 5 | 0.020 |
Why?
|
| K562 Cells | 1 | 2005 | 4 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2005 | 8 | 0.020 |
Why?
|
| Virus Integration | 1 | 2005 | 3 | 0.020 |
Why?
|
| Hela Cells | 1 | 2005 | 77 | 0.020 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2004 | 4 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 30 | 0.020 |
Why?
|
| Transplantation | 1 | 2004 | 16 | 0.020 |
Why?
|
| Cell Count | 1 | 2004 | 52 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2004 | 4 | 0.020 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2004 | 6 | 0.020 |
Why?
|
| Brain Tissue Transplantation | 1 | 2004 | 4 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 27 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 100 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 143 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2004 | 163 | 0.020 |
Why?
|
| X Chromosome | 1 | 2002 | 25 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2002 | 35 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 70 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 116 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 466 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 895 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 1098 | 0.010 |
Why?
|
| Child | 1 | 2002 | 2010 | 0.010 |
Why?
|